🇺🇸 FDA
Pipeline program

medication for opioid use disorder

R01DA033671

Approved small_molecule completed

Quick answer

medication for opioid use disorder for Opioid Use Disorder is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid Use Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials